Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

6.35
Delayed Data
As of 1:39pm ET
 -0.19 / -2.91%
Today’s Change
3.71
Today|||52-Week Range
14.80
+39.25%
Year-to-Date

Today’s Trading

Previous close6.54
Today’s open6.55
Day’s range6.25 - 6.56
Volume174,150
Average volume (3 months)209,370
Market cap$70.8M
Dividend yield--
Data as of 1:39pm ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)-5.08%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.18

Competitors

 Today’s
change
Today’s
% change
REPHRecro Pharma Inc-0.12-1.32%
AVEOAveo Pharmaceuticals...+0.02+1.46%
ADMPAdamis Pharmaceutica...-1.56-28.94%
CRBPCorbus Pharmaceutica...+0.03+1.08%
Data as of 1:39pm ET, 03/30/2015

Financials

Last reporting dateJanuary 28, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$5.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account